J C Marsh, R C DeConti, S P Hubbard. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Adenocarcinoma/drug therapyAdenoma, Islet Cell/drug therapyAdolescentAdrenal Gland Neoplasms/drug therapyAdultAlkylating Agents/therapeutic useBreast Neoplasms/drug therapyCarcinoma, Squamous Cell/drug therapyCarmustine/adverse effectsCarmustine/therapeutic useClinical Trials as TopicColonic Neoplasms/drug therapyEvaluation Studies as TopicFemaleGastrointestinal Neoplasms/drug therapyGlioblastoma/drug therapyHemorrhage/chemically inducedHodgkin Disease/drug therapyHumansLeukemia, Lymphoid/drug therapyLymphoma, Large B-Cell, Diffuse/drug therapyMaleMelanoma/drug therapyMiddle AgedNeoplasms/drug therapyNitroso Compounds/therapeutic useOvarian Neoplasms/drug therapySarcoma/drug therapySarcoma, Ewing/drug therapyStomach Neoplasms/drug therapyThrombocytopenia/chemically inducedTongue Neoplasms/drug therapyUrea/therapeutic use
Substances： See more » Alkylating AgentsNitroso CompoundsUreaCarmustine
Year: 1971 PMID： 4334161
Source DB: PubMed Journal: Cancer Chemother Rep ISSN： 0069-0112